novel agents and clinical trials emerging for the treatment of al amyloidosis
Published 2 years ago • 57 plays • Length 3:23Download video MP4
Download video MP3
Similar videos
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
5:07
daratumumab in the management of al amyloidosis
-
2:57
novel targeted therapies for the treatment of bpdcn
-
2:44
novel bcma-targeting therapies to treat tce relapsed/refractory multiple myeloma
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
0:57
novel therapeutic strategies in all
-
2:56
early vs. deferred transplantation in al amyloidosis
-
10:30
scd highlights at ash 2023: disease pathogenesis, ongoing clinical trials & novel gene therapies
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
1:02
maintenance therapy following treatment for amyloidosis
-
6:41
clinical trials aiming to reduce the toxicity of novel agents in aml
-
12:03
how will novel agents affect the amyloidosis population?
-
5:16
the evolution of al amyloidosis therapy
-
3:19
supportive care in al amyloidosis